Found 36 matching trials
A Phase II Study of Icotinib in Treating Patients With Advanced Nasopharyngeal Carcinoma
PHASE2This is a phase 2 study to evaluate the efficacy of single-agent icotinib i...
Location
Multiple Locations
Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation
PHASE1The purpose of this study is to evaluate the safety and tolerability of Ico...
Location
West China Hospital
Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer
PHASE2To investigate the efficacy and toxicity of EGFR tyrosine-kinase inhibitor ...
Location
Hangzhou Cancer Hospital
Study of Icotinib Hydrochloride in Treating Patients With Recurrent or Metastatic Esophageal Cancer After Failure of Conventional Chemotherapy
PHASE2Phase II Study of Icotinib Hydrochloride in Treating Patients With Recurren...
Location
Sun Yat-sen University Cancer Center
Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma
PHASE3The investigators performed a randomized, double blind controlled, prospect...
Location
Multiple Locations
Icotinib for Completed Resected IB NSCLC With EGFR Mutation
PHASE2This phase II trial studies how well icotinib works in treating patients wi...
Location
Sun Yat-sen University Cancer Center
Befotertinib and Icotinib for NSCLC With Uncommon EGFR Mutations
PHASE2This research study aims to explore the combination of two targeted drugs a...
Location
Sun Yat-sen University Cancer Center
Icotinib as Neoadjuvant and Adjuvant Therapy in EGFR-mutant Stage IIIB or Oligometastasis Non-small Cell Lung Cancer
PHASE2The main purpose of this study is to evaluate the pulmonary and metastases ...
Location
Cancer Hospital, Chinese Academy of Medical Science
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation
PHASE4This is a randomized ,opened, prospective controlled trial of clinical effe...
Location
PLA General Hospital
Icotinib as Neoadjuvant Therapy in EGFR-mutant Stage ā
¢A-N2 Non-small Cell Lung Cancer
PHASE2The main purpose of this study is to evaluate the efficacy and safety of Ic...
Location
Cancer Hospital, Chinese Academy of Medical Science